Mauritania vs Solomon Islands: Hepatitis B surface antigen (HBsAg) prevalence
Mauritania
1.4%
in 2024
Solomon Islands
1.4%
in 2024
Mauritania rank
19th
Solomon Islands rank
19th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Mauritania
- Solomon Islands
How they compare
Mauritania currently reports 1.4% against 1.4% in Solomon Islands, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Mauritania ahead.
Mauritania ranks 19th and Solomon Islands ranks 19th of 194 countries.
Across the 2 decades both report, Mauritania averaged higher in 1 and Solomon Islands in 1.
Head to head by decade
| Decade | Mauritania | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.8% | 2.1% | 0.7% | Mauritania |
| 2020s | 1.6% | 1.6% | 0.0% | Solomon Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Mauritania or Solomon Islands?
- Mauritania, at 1.4% against 1.4% in Solomon Islands as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Mauritania and Solomon Islands?
- 0.0%, with Mauritania ahead.
- How many years of comparable data are there for Mauritania and Solomon Islands?
- 10 years are reported by both, from 2015 to 2024.
- How do Mauritania and Solomon Islands rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Mauritania ranks 19th and Solomon Islands ranks 19th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.